Yekeduz, E. Et Al. 2022. The prognostic role of polypharmacy in metastatic colorectal cancer patients treated with regorafenib. FUTURE ONCOLOGY , vol.18 , 1067-1076.

Yekeduz, E., Aktas, E. G., KÖKSOY, E. B., Dogan, N., ÜRÜN, Y., & UTKAN, G., (2022). The prognostic role of polypharmacy in metastatic colorectal cancer patients treated with regorafenib. FUTURE ONCOLOGY , vol.18, 1067-1076.

Yekeduz, EMRE Et Al. "The prognostic role of polypharmacy in metastatic colorectal cancer patients treated with regorafenib," FUTURE ONCOLOGY , vol.18, 1067-1076, 2022

Yekeduz, EMRE Et Al. "The prognostic role of polypharmacy in metastatic colorectal cancer patients treated with regorafenib." FUTURE ONCOLOGY , vol.18, pp.1067-1076, 2022

Yekeduz, E. Et Al. (2022) . "The prognostic role of polypharmacy in metastatic colorectal cancer patients treated with regorafenib." FUTURE ONCOLOGY , vol.18, pp.1067-1076.

@article{article, author={EMRE YEKEDÜZ Et Al. }, title={The prognostic role of polypharmacy in metastatic colorectal cancer patients treated with regorafenib}, journal={FUTURE ONCOLOGY}, year=2022, pages={1067-1076} }